A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.
The healthcare sector employs approximately 10 per cent of workers in the European Union and is therefore one of the largest employment sectors, encompassing a wide range of professions.
Workers in the healthcare sector face different risks related to the use of chemicals and drugs on a daily basis, which can cause skin or respiratory reactions. These professionals are exposed to disinfectants, anaesthetic gases, detergents and other agents used to maintain a hygienic and safe environment for patients. However, this exposure can lead to negative health consequences, such as skin reactions like urticaria and contact dermatitis, often caused by irritation or toxicity of the substances in use. In addition, inhalation of such substances can lead to respiratory disorders, such as allergic rhinitis or even asthma, highlighting the complexity of risks faced by workers in the healthcare sector.
Recently, an increase in the frequency of certain gram-negative bacteria has been observed in hospital care, such as carbapenemase-producing enterobacteria and Acinetobacter spp., which have become responsible for severe infections. These infections pose an additional threat to hospital workers, especially considering the context of the recent Sars-CoV-2 pandemic, which saw an increase in cases of acute respiratory illness. The emergence of these new respiratory pathogens has highlighted the vulnerability of healthcare workers to respiratory tract infections, underlining the importance of personal protective equipment (PPE) respirators to reduce occupational risk when vaccination or specific treatments are not available.
The use of FFP2 and FFP3 masks is crucial to protect healthcare workers from a wide range of biological agents, including those belonging to group 2 (agents risky for workers who are unlikely to spread in the community and for whom effective prophylactic or therapeutic measures are available), group 3 (agents risky for workers who are unlikely to spread in the community and for whom effective prophylactic or therapeutic measures are available) and also some group 4 (agents risky for workers who are unlikely to spread in the community and for whom effective prophylactic or therapeutic measures are available). These devices offer effective protection against aerosols and airborne particles, which are especially essential during procedures with a risk of airborne transmission such as bronchoscopies. In contrast, surgical masks provide limited protection against large droplets and are not suitable to protect against airborne pathogens. Therefore, the correct selection and use of respiratory PPE is crucial to ensure the safety and health of healthcare workers during exposure to potential infectious risks.
Recent studies have shown that the use of FFP2 masks during the entire work shift provides significant protection from respiratory infections compared to those who do not use PPE or wear surgical masks. It was also confirmed that the use of masks is essential as part of infection control measures in hospitals to reduce the risk of respiratory infections among healthcare personnel. Furthermore, FFP2/FFP3 masks are particularly recommended during medical procedures that may generate aerosols, such as performing nasopharyngeal swabs, non-invasive ventilation and other invasive respiratory tract procedures, helping to ensure a safe working environment for healthcare workers.
Recommended products:
Safety first non solo sul luogo di lavoro ma anche negli ambienti urbani. Proteggersi deve essere una priorità, non solo sul luogo di lavoro ma anche nella vita di tutti i giorni. I valori preoccupanti di inquinamento in questi giorni a Milano ci fanno riflettere su come l’aria che respiriamo quotidianamente possa influire negativamente sulla […]
Facciamo le nostre congratulazioni al campione di Yamaha Motor Racing domenica 24 aprile 2022 Fabio Quartararo è arrivato primo al Grande Prémio de Portugal, con la gara che si è tenuta ad Algarve domenica 24 aprile. La gara Il meteo sopra all'Autódromo Internacional do Algarve non era dei migliori prima dell'inizio della […]
Affrontare il rischio residuo: i DPI Come nascono i DPI? Nell’ambiente lavorativo rischi e pericoli vanno gestiti con protocolli orientati a ridurne al minimo l’entità. Il datore di lavoro, infatti, è tenuto a valutare tutti i rischi presenti in azienda, per fare in modo che ogni fattore di rischio possa essere annullato o, se non […]
BLS S.R.L.
Empresa com um único membro
via dei Giovi, 41 - 20032 Cormano (MI) - Itália
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Política de privacidade - Política de cookies
Sede legal
via dei Giovi, 41 - 20032 Cormano (MI) - Itália
Capital social: Euro 600.000,00 i.v.
C.C.I.A. - R.E.A.: MI 1186898
Número de IVA: IT12296780153
Código fiscal e entrada no Registro de Empresas de Milão: 07822320151
BLS IBÉRIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Espanha
BLS NOROESTE / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - Países Baixos
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 São Paulo - SP - Brasil
BLS ALEMANHA / Dünner Straße 249 D-41066 Mönchengladbach - Alemanha
BLS FRANÇA / 18 Porte du Grand Lyon 01700 Neyron - França
